Mark S. Co, DPM
- Medicare patients, 2024
- 350
- Part D claims, 2024
- 110
- MIPS score, 2024
- 66
- Hospital affiliations
- 1
- Industry payments
- $138
- Practice address
- 45 Castro St Lbby, San Francisco, CA 94114
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
California Pacific Medical Ctr-Davies Campus Hosp - HOPD (45 Castro St Lbby)
Acute Care Hospital outpatient department · San Francisco, California
Find Mark Co's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Mark S. Co is a podiatric surgeon in San Francisco, California
Mark Co practices at California Pacific Medical Ctr-Davies Campus Hosp - HOPD (45 Castro St Lbby) in San Francisco, California.
Mark Co's NPI, 1124316005, was assigned on July 13, 2011. Mark Co holds California license E4954.
- NPI
- 1124316005NPI Registry (opens in a new tab)
- Medicare PAC ID
- 8628233079
- NPI enumeration date
- July 13, 2011
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 43
- Medical school graduation
- 2009
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Mark S. Co practices at California Pacific Medical Ctr-Davies Campus Hosp - HOPD (45 Castro St Lbby) in San Francisco, California
Mark Co's primary practice is California Pacific Medical Ctr-Davies Campus Hosp - HOPD (45 Castro St Lbby), at 45 Castro St Lbby, San Francisco, CA 94114.
- California Pacific Medical Ctr-Davies Campus Hosp - HOPD (45 Castro St Lbby)45 Castro St Lbby, San Francisco, CA 94114
Source: Dmand AI Affiliation Data
Mark S. Co is affiliated with 2 sites of care and 1 medical group
Mark Co's primary practice is California Pacific Medical Ctr-Davies Campus Hosp - HOPD (45 Castro St Lbby) in San Francisco, California. Mark Co is also affiliated with California Pacific Medical Center Davies Campus. The medical group on file is Northern California Foot & Ankle Center.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Mark S. Co's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Mark Co practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| California Pacific Medical Ctr-Davies Campus Hosp - HOPD (45 Castro St Lbby) | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Mark S. Co is one of 1,112 podiatric surgeons in California
Foot and ankle surgery is Mark Co's primary specialty in the NPI Registry, under taxonomy code 213ES0103X. Mark Co is licensed in California.
Specialties and state licenses
- Foot and ankle surgery podiatrist, CaliforniaPrimary
Podiatric surgeons near Mark Co
Counts of podiatric surgeons with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Mark S. Co treated 350 Medicare patients in 2024, average age 74
CMS counts 350 Medicare patients who saw Mark Co in 2024. The largest group is 65 to 74, with 162 patients. 74% of them have high cholesterol, and 65% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Mark Co's median patient age at 61, with 36% women.
Mark Co's Medicare patients by age, 2024
Mark Co's Medicare patients by sex, 2024
- Women12937%
- Men22163%
Chronic conditions among Mark Co's Medicare patients, 2024
- High cholesterol74%
- High blood pressure65%
- Arthritis40%
- Mood disorders32%
- Depression27%
- Diabetes26%
- Anxiety24%
- Ischemic heart disease22%
Share of Medicare patients with each condition. A patient can have several.
Mark Co's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 61
Patient panel by sex, all payers
- Women36%
- Men53%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Mark S. Co wrote 110 Medicare Part D claims in 2024
In 2024, Mark Co wrote 110 Medicare Part D claims for 47 patients. 78% of them were for generic drugs.
Mark Co's Part D claims by kind of drug, 2024
- Generic86 claims78%
- Brand-name24 claims22%
Source: Medicare Part D Prescribers - by Provider (CMS), 2024 data
Mark S. Co scored 66 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 66 out of 100 for Mark Co for performance year 2024, reported individually. Mark Co accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 558 procedures of removal or shaving of skin growth by Mark Co, more than 96% of the clinicians it reports for that procedure.
- Accepts Medicare assignment
- Yes
Mark Co's MIPS scores, performance year 2024
- 66of 100Final score
- 62.3of 100Quality
- 100of 100Promoting Interoperability
- 0of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Where Mark Co ranks in Medicare procedure volume
- Removal of nail tissue
- 89th percentile780 procedures
- Removal or shaving of skin growth
- 96th percentile558 procedures
- Removal of tissue
- 84th percentile84 procedures
- Removal of skin lesions
- 67th percentile26 procedures
CMS ranks each clinician against every clinician it reports for the same procedure category.
Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Mark S. Co received $138 in industry payments in 2025
CMS Open Payments shows 2 general payments to Mark Co from 2 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. TissueTech, Inc. paid the most, $116.
Companies that paid Mark Co the most, 2025 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Mark S. Co's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Mark S. Co
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Mark S. Co's NPI number?
Mark S. Co's NPI number is 1124316005. It was assigned on July 13, 2011, and it is active in the NPI Registry.
What does Mark S. Co specialize in?
Mark S. Co is a podiatric surgeon in San Francisco, California. The primary specialty in the NPI Registry is Foot & Ankle Surgery Podiatrist (taxonomy code 213ES0103X).
Where does Mark S. Co practice?
Mark Co practices at 45 Castro St Lbby, San Francisco, CA 94114. Mark Co's primary practice is California Pacific Medical Ctr-Davies Campus Hosp - HOPD (45 Castro St Lbby) in San Francisco, California.
What is Mark S. Co's medical license number?
Mark Co holds California license E4954.
Which hospitals is Mark S. Co affiliated with?
Mark Co is affiliated with California Pacific Medical Center Davies Campus.
What medical group is Mark S. Co part of?
Mark Co is linked to Northern California Foot & Ankle Center.
Does Mark S. Co accept Medicare?
Yes. CMS lists Mark Co as accepting Medicare assignment.
What is Mark S. Co's MIPS score?
Mark Co's MIPS final score for performance year 2024 is 66 out of 100, reported individually.
How many Medicare patients does Mark S. Co see?
CMS counts 350 Medicare patients who saw Mark Co in 2024, with an average age of 74.
Has Mark S. Co received payments from drug or device companies?
CMS Open Payments shows $138 in general payments to Mark Co from 2 companies from 2025 to 2025. The largest total came from TissueTech, Inc.
How long has Mark S. Co been practicing?
Mark Co graduated from medical school in 2009, 17 years ago.
Selling to foot and ankle surgery practices?
See podiatric surgeons in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card